Mark W. Parrish joins Mylan’s board of directors

PITTSBURGH Mylan has elected a new member to its board of directors.

Mark W. Parrish, chairman and CEO of Trident USA Health Services, the nation's largest provider of mobile X-ray and laboratory services to the long-term care industry, has joined Mylan’s board. In addition to his current role at Trident, Parrish also is president of the International Federation of Pharmaceutical Wholesalers, an association comprised of the largest pharmaceutical wholesalers and pharmaceutical supply chain service companies in the world. He also serves as a senior adviser to Frazier Healthcare Ventures, a healthcare-oriented growth equity firm, and as a director of Biovail Corp.

Previously, Parrish was CEO of Healthcare Supply Chain Services for Cardinal Health, a $91 billion global manufacturer and distributor of medical and surgical supplies and technologies. Parrish also held a variety of other leadership roles at Cardinal Health including group president, Pharmaceutical Supply Chain Services; president and COO, Pharmaceutical Supply Chain Services; chairman and CEO, Pharmaceutical Distribution and Provider Services; EVP and group president, Pharmaceutical Distribution; and president, Medicine Shoppe.

"I am honored to have this tremendous opportunity to serve as a Mylan director," said Parrish. "Throughout my career, Mylan always has stood out among generic pharmaceutical manufacturers as having an unbeatable reputation for quality, reliability and affordability."